title: [The use of a daily dose of methylprednisolone (Medrol) once in treating hemoblastoses].
authors.forename: G V
authors.initials: GV
authors.lastname: Kruglova
authors.forename: I V
authors.initials: IV
authors.lastname: Poddubnaia
authors.forename: I A
authors.initials: IA
authors.lastname: Finogenova
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D013607:Tablets
chemical_list: D013607:Tablets; D008775:Methylprednisolone
vernacular_title: Primenenie sutochnoĭ dozy metilprednizolona (Medrola) odnokratno pri lechenii nekotorykh gemoblastozov.